Tycho Peterson
Stock Analyst at Jefferies
(2.60)
# 1,979
Out of 4,829 analysts
134
Total ratings
40%
Success rate
35.89%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $59.00 | +35.59% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $37.41 | +17.62% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,174.59 | -6.35% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $200.83 | +29.46% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $251.01 | +15.53% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $8.51 | +158.67% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $175.78 | +5.25% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $58.81 | +44.53% | 7 | Dec 10, 2024 | |
| QGEN Qiagen | Assumes: Buy | $43 → $56 | $42.94 | +29.54% | 5 | Dec 10, 2024 | |
| WAT Waters | Upgrades: Buy | $355 → $415 | $366.67 | +13.18% | 7 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $32.95 | +6.22% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $98.64 | +26.72% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $9.49 | +152.90% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.10 | +263.64% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.73 | +310.96% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $157.29 | -9.72% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $41.66 | -23.19% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $81.26 | +41.52% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $4.25 | +370.59% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $432.59 | +50.26% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $13.50 | -33.31% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.94 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.90 | +533.25% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $5.73 | +947.12% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.19 | +622.14% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $143.08 | +172.57% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $150 | $115.55 | +29.81% | 7 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $1.17 | +1,874.25% | 1 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.68 | +572.90% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $561.43 | -64.38% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $18.56 | +29.31% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $16.75 | +168.66% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $160 | $0.13 | +122,976.92% | 4 | Sep 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $133.72 | -47.65% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $156.13 | -23.14% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.66 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.26 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $16.61 | +231.13% | 1 | Jul 19, 2016 |
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $59.00
Upside: +35.59%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $37.41
Upside: +17.62%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,174.59
Upside: -6.35%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $200.83
Upside: +29.46%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $251.01
Upside: +15.53%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $8.51
Upside: +158.67%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $175.78
Upside: +5.25%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $58.81
Upside: +44.53%
Qiagen
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $42.94
Upside: +29.54%
Waters
Oct 8, 2024
Upgrades: Buy
Price Target: $355 → $415
Current: $366.67
Upside: +13.18%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $32.95
Upside: +6.22%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $98.64
Upside: +26.72%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $9.49
Upside: +152.90%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.10
Upside: +263.64%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.73
Upside: +310.96%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $157.29
Upside: -9.72%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $41.66
Upside: -23.19%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $81.26
Upside: +41.52%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $4.25
Upside: +370.59%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $432.59
Upside: +50.26%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $13.50
Upside: -33.31%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.94
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.90
Upside: +533.25%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $5.73
Upside: +947.12%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.19
Upside: +622.14%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $143.08
Upside: +172.57%
May 26, 2021
Maintains: Overweight
Price Target: $140 → $150
Current: $115.55
Upside: +29.81%
May 11, 2021
Initiates: Overweight
Price Target: $23
Current: $1.17
Upside: +1,874.25%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.68
Upside: +572.90%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $561.43
Upside: -64.38%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $18.56
Upside: +29.31%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $16.75
Upside: +168.66%
Sep 27, 2019
Downgrades: Underweight
Price Target: $160
Current: $0.13
Upside: +122,976.92%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $133.72
Upside: -47.65%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $156.13
Upside: -23.14%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.66
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $40.26
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $16.61
Upside: +231.13%